Literature DB >> 19895668

Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.

Ping Zhang1, Kyle M Lokuta, Deanne E Turner, Bin Liu.   

Abstract

Overexposure to manganese is known to cause damage to basal ganglial neurons and the development of movement abnormalities. Activation of microglia and astrocytes has increasingly been associated with the pathogenesis of a variety of neurological disorders. We have recently shown that microglial activation facilitates manganese chloride (MnCl2, 10-300 microM)-induced preferential degeneration of dopamine (DA) neurons. In this study, we report that combinations of MnCl2 (1-30 microM) and endotoxin lipopolysaccharide (LPS, 0.5-2 ng/mL), at minimally effective concentrations when used alone, induced synergistic and preferential damage to DA neurons in rat primary neuron-glia cultures. Mechanistically, MnCl2 significantly potentiated LPS-induced release of tumor necrosis factor-alpha and interleukin-1 beta in microglia, but not in astroglia. MnCl2 and LPS were more effective in inducing the formation of reactive oxygen species and nitric oxide in microglia than in astroglia. Furthermore, MnCl2 and LPS-induced free radical generation, cytokine release, and DA neurotoxicity was significantly attenuated by pre-treatment with potential anti-inflammatory agents minocycline and naloxone. These results demonstrate that the combination of manganese overexposure and neuroinflammation is preferentially deleterious to DA neurons. Moreover, these findings not only shed light on the understanding of manganese neurotoxicity but may also bear relevance to the potentially multifactorial etiology of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895668      PMCID: PMC2809141          DOI: 10.1111/j.1471-4159.2009.06477.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  65 in total

1.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

Authors:  J M Gorell; C C Johnson; B A Rybicki; E L Peterson; G X Kortsha; G G Brown; R J Richardson
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

2.  Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease.

Authors:  Jason R Richardson; W Michael Caudle; Minzheng Wang; E Danielle Dean; Kurt D Pennell; Gary W Miller
Journal:  FASEB J       Date:  2006-06-29       Impact factor: 5.191

Review 3.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways.

Authors:  Julie A Moreno; Kelly A Sullivan; David L Carbone; William H Hanneman; Ronald B Tjalkens
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

Review 5.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

Review 6.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

7.  Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB.

Authors:  Rola Barhoumi; Jennifer Faske; Xuhong Liu; Ronald B Tjalkens
Journal:  Brain Res Mol Brain Res       Date:  2004-03-30

8.  Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

Authors:  E-K Tan; C Tan; S M C Fook-Chong; S Y Lum; A Chai; H Chung; H Shen; Y Zhao; M L Teoh; Y Yih; R Pavanni; V R Chandran; M C Wong
Journal:  J Neurol Sci       Date:  2003-12-15       Impact factor: 3.181

9.  Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Authors:  Hui-Ming Gao; Bin Liu; Wanqin Zhang; Jau-Shyong Hong
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

Review 10.  Minocycline and neurodegenerative diseases.

Authors:  Hye-Sun Kim; Yoo-Hun Suh
Journal:  Behav Brain Res       Date:  2008-10-11       Impact factor: 3.332

View more
  29 in total

1.  Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output.

Authors:  Celia A Dodd; Nikolay M Filipov
Journal:  Neurotoxicology       Date:  2011-09-25       Impact factor: 4.294

2.  Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells.

Authors:  Patrick L Crittenden; Nikolay M Filipov
Journal:  J Appl Toxicol       Date:  2011-01       Impact factor: 3.446

3.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Authors:  Dejan Milatovic; Ramesh C Gupta; Yingchun Yu; Snjezana Zaja-Milatovic; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

Review 4.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 5.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

6.  Sodium P-aminosalicylic Acid Attenuates Manganese-Induced Neuroinflammation in BV2 Microglia by Modulating NF-κB Pathway.

Authors:  Junyan Li; Yue Deng; Dongjie Peng; Lin Zhao; Yuanyuan Fang; Xiaojuan Zhu; Shaojun Li; Michael Aschner; Shiyan Ou; Yueming Jiang
Journal:  Biol Trace Elem Res       Date:  2021-01-14       Impact factor: 3.738

7.  Melatonin Attenuates Manganese and Lipopolysaccharide-Induced Inflammatory Activation of BV2 Microglia.

Authors:  Euteum Park; Hong Sung Chun
Journal:  Neurochem Res       Date:  2016-11-30       Impact factor: 3.996

Review 8.  Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.

Authors:  Ryan Bachtell; Mark R Hutchinson; Xiaohui Wang; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

9.  Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Authors:  Randall L Davis; Subhas Das; Daniel J Buck; Craig W Stevens
Journal:  Neurochem Int       Date:  2013-01-31       Impact factor: 3.921

Review 10.  The liver-brain axis in liver failure: neuroinflammation and encephalopathy.

Authors:  Roger F Butterworth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.